APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Recombinant Protein Production Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Recombinant Protein Production Service Market Outlook and Growth Opportunities 2026

1 May 2026197 pages

Choose your research edition.

Industry ResearchCustom Recombinant Protein Production Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Recombinant Protein Production Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Custom Recombinant Protein Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Recombinant Protein Production Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Recombinant Protein Production Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Custom Recombinant Protein Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Recombinant Protein Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Recombinant Protein Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Recombinant Protein Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Recombinant Protein Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Recombinant Protein Production Service market include VectorBuilder, Proteos, Creative Biolabs, Charles River, InVivo BioTech Services GmbH, eEnzyme, BiologicsCorp, Biomatik and RayBiotech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Recombinant Protein Production Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Recombinant Protein Production Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Recombinant Protein Production Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Recombinant Protein Production Service market.

Custom Recombinant Protein Production Service Segment by Company

VectorBuilder

Proteos

Creative Biolabs

Charles River

InVivo BioTech Services GmbH

eEnzyme

BiologicsCorp

Biomatik

RayBiotech

R&D Systems

OriGene Technologies

Applied Biological Materials Inc. (abm)

Creative BioMart

Levprot Bioscience

Jubilant Biosys

Kinexus Bioinformatics

NorthX Biologics

Leinco Technologies

GenScript

KACTUS

G &P Biosciences

Boster Bio

Eurofins Discovery

Custom Recombinant Protein Production Service Segment by Type

Mammalian Cell Based

Bacteria Based

Insect Cell Based

Others

Custom Recombinant Protein Production Service Segment by Application

Basic Scientific Research

Monoclonal Antibody Drug Development

Therapeutic Protein Production

Mrna Vaccine Research

Others

Custom Recombinant Protein Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Recombinant Protein Production Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Recombinant Protein Production Service key companies, revenue, market share, and recent developments.

3. To split the Custom Recombinant Protein Production Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Recombinant Protein Production Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Recombinant Protein Production Service significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Recombinant Protein Production Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Recombinant Protein Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Recombinant Protein Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Recombinant Protein Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Recombinant Protein Production Service industry.

Chapter 3: Detailed analysis of Custom Recombinant Protein Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Recombinant Protein Production Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Recombinant Protein Production Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Recombinant Protein Production Service Industry Trends Table 2. Custom Recombinant Protein Production Service Industry Drivers Table 3. Custom Recombinant Protein Production Service Industry Opportunities and Challenges Table 4. Custom Recombinant Protein Production Service Industry Restraints Table 5. Global Custom Recombinant Protein Production Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Recombinant Protein Production Service Revenue Share by Company (2021-2026) Table 7. Global Custom Recombinant Protein Production Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Recombinant Protein Production Service Key Company Manufacturing Base & Headquarters Table 9. Global Custom Recombinant Protein Production Service Company, Product Type & Application Table 10. Global Custom Recombinant Protein Production Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Recombinant Protein Production Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Mammalian Cell Based Table 15. Significant Companies of Bacteria Based Table 16. Significant Companies of Insect Cell Based Table 17. Significant Companies of Others Table 18. Global Custom Recombinant Protein Production Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Custom Recombinant Protein Production Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Custom Recombinant Protein Production Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Custom Recombinant Protein Production Service Sales Value Share by Type (2021-2026) Table 22. Global Custom Recombinant Protein Production Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Basic Scientific Research Table 24. Significant Companies of Monoclonal Antibody Drug Development Table 25. Significant Companies of Therapeutic Protein Production Table 26. Significant Companies of Mrna Vaccine Research Table 27. Significant Companies of Others Table 28. Global Custom Recombinant Protein Production Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Custom Recombinant Protein Production Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Custom Recombinant Protein Production Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Custom Recombinant Protein Production Service Sales Value Share by Application (2021-2026) Table 32. Global Custom Recombinant Protein Production Service Sales Value Share by Application (2027-2032) Table 33. Global Custom Recombinant Protein Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Custom Recombinant Protein Production Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Custom Recombinant Protein Production Service Sales Value Share by Region (2021-2026) Table 36. Global Custom Recombinant Protein Production Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Custom Recombinant Protein Production Service Sales Value Share by Region (2027-2032) Table 38. Global Custom Recombinant Protein Production Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Custom Recombinant Protein Production Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Custom Recombinant Protein Production Service Sales Value Market Share by Country (2021-2026) Table 41. Global Custom Recombinant Protein Production Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Custom Recombinant Protein Production Service Sales Value Market Share by Country (2027-2032) Table 43. VectorBuilder Company Information Table 44. VectorBuilder Business Overview Table 45. VectorBuilder Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. VectorBuilder Custom Recombinant Protein Production Service Product Portfolio Table 47. VectorBuilder Recent Development Table 48. Proteos Company Information Table 49. Proteos Business Overview Table 50. Proteos Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Proteos Custom Recombinant Protein Production Service Product Portfolio Table 52. Proteos Recent Development Table 53. Creative Biolabs Company Information Table 54. Creative Biolabs Business Overview Table 55. Creative Biolabs Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Creative Biolabs Custom Recombinant Protein Production Service Product Portfolio Table 57. Creative Biolabs Recent Development Table 58. Charles River Company Information Table 59. Charles River Business Overview Table 60. Charles River Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Charles River Custom Recombinant Protein Production Service Product Portfolio Table 62. Charles River Recent Development Table 63. InVivo BioTech Services GmbH Company Information Table 64. InVivo BioTech Services GmbH Business Overview Table 65. InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Product Portfolio Table 67. InVivo BioTech Services GmbH Recent Development Table 68. eEnzyme Company Information Table 69. eEnzyme Business Overview Table 70. eEnzyme Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. eEnzyme Custom Recombinant Protein Production Service Product Portfolio Table 72. eEnzyme Recent Development Table 73. BiologicsCorp Company Information Table 74. BiologicsCorp Business Overview Table 75. BiologicsCorp Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. BiologicsCorp Custom Recombinant Protein Production Service Product Portfolio Table 77. BiologicsCorp Recent Development Table 78. Biomatik Company Information Table 79. Biomatik Business Overview Table 80. Biomatik Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Biomatik Custom Recombinant Protein Production Service Product Portfolio Table 82. Biomatik Recent Development Table 83. RayBiotech Company Information Table 84. RayBiotech Business Overview Table 85. RayBiotech Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. RayBiotech Custom Recombinant Protein Production Service Product Portfolio Table 87. RayBiotech Recent Development Table 88. R&D Systems Company Information Table 89. R&D Systems Business Overview Table 90. R&D Systems Custom Recombinant Protein Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. R&D Systems Custom Recombinant Protein Production Service Product Portfolio Table 92. R&D Systems Recent Development Table 93. OriGene Technologies Company Information Table 94. OriGene Technologies Business Overview Table 95. OriGene Technologies Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. OriGene Technologies Custom Recombinant Protein Production Service Product Portfolio Table 97. OriGene Technologies Recent Development Table 98. Applied Biological Materials Inc. (abm) Company Information Table 99. Applied Biological Materials Inc. (abm) Business Overview Table 100. Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Product Portfolio Table 102. Applied Biological Materials Inc. (abm) Recent Development Table 103. Creative BioMart Company Information Table 104. Creative BioMart Business Overview Table 105. Creative BioMart Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Creative BioMart Custom Recombinant Protein Production Service Product Portfolio Table 107. Creative BioMart Recent Development Table 108. Levprot Bioscience Company Information Table 109. Levprot Bioscience Business Overview Table 110. Levprot Bioscience Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Levprot Bioscience Custom Recombinant Protein Production Service Product Portfolio Table 112. Levprot Bioscience Recent Development Table 113. Jubilant Biosys Company Information Table 114. Jubilant Biosys Business Overview Table 115. Jubilant Biosys Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Jubilant Biosys Custom Recombinant Protein Production Service Product Portfolio Table 117. Jubilant Biosys Recent Development Table 118. Kinexus Bioinformatics Company Information Table 119. Kinexus Bioinformatics Business Overview Table 120. Kinexus Bioinformatics Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Kinexus Bioinformatics Custom Recombinant Protein Production Service Product Portfolio Table 122. Kinexus Bioinformatics Recent Development Table 123. NorthX Biologics Company Information Table 124. NorthX Biologics Business Overview Table 125. NorthX Biologics Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. NorthX Biologics Custom Recombinant Protein Production Service Product Portfolio Table 127. NorthX Biologics Recent Development Table 128. Leinco Technologies Company Information Table 129. Leinco Technologies Business Overview Table 130. Leinco Technologies Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Leinco Technologies Custom Recombinant Protein Production Service Product Portfolio Table 132. Leinco Technologies Recent Development Table 133. GenScript Company Information Table 134. GenScript Business Overview Table 135. GenScript Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. GenScript Custom Recombinant Protein Production Service Product Portfolio Table 137. GenScript Recent Development Table 138. KACTUS Company Information Table 139. KACTUS Business Overview Table 140. KACTUS Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. KACTUS Custom Recombinant Protein Production Service Product Portfolio Table 142. KACTUS Recent Development Table 143. G &P Biosciences Company Information Table 144. G &P Biosciences Business Overview Table 145. G &P Biosciences Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. G &P Biosciences Custom Recombinant Protein Production Service Product Portfolio Table 147. G &P Biosciences Recent Development Table 148. Boster Bio Company Information Table 149. Boster Bio Business Overview Table 150. Boster Bio Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Boster Bio Custom Recombinant Protein Production Service Product Portfolio Table 152. Boster Bio Recent Development Table 153. Eurofins Discovery Company Information Table 154. Eurofins Discovery Business Overview Table 155. Eurofins Discovery Custom Recombinant Protein Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Eurofins Discovery Custom Recombinant Protein Production Service Product Portfolio Table 157. Eurofins Discovery Recent Development Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Custom Recombinant Protein Production Service Product Image Figure 2. Global Custom Recombinant Protein Production Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Recombinant Protein Production Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Recombinant Protein Production Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Mammalian Cell Based Image Figure 8. Bacteria Based Image Figure 9. Insect Cell Based Image Figure 10. Others Image Figure 11. Global Custom Recombinant Protein Production Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Custom Recombinant Protein Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Custom Recombinant Protein Production Service Sales Value Share by Type (2021-2032) Figure 14. Basic Scientific Research Image Figure 15. Monoclonal Antibody Drug Development Image Figure 16. Therapeutic Protein Production Image Figure 17. Mrna Vaccine Research Image Figure 18. Others Image Figure 19. Global Custom Recombinant Protein Production Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Custom Recombinant Protein Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Custom Recombinant Protein Production Service Sales Value Share by Application (2021-2032) Figure 22. Global Custom Recombinant Protein Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Custom Recombinant Protein Production Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Custom Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Custom Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Custom Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Custom Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Custom Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Custom Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Custom Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Custom Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Custom Recombinant Protein Production Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Custom Recombinant Protein Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Mammalian Cell Based
  • Bacteria Based
  • Insect Cell Based
  • Others
Applications
  • Basic Scientific Research
  • Monoclonal Antibody Drug Development
  • Therapeutic Protein Production
  • Mrna Vaccine Research
  • Others
Companies covered
  • VectorBuilder
  • Proteos
  • Creative Biolabs
  • Charles River
  • InVivo BioTech Services GmbH
  • eEnzyme
  • BiologicsCorp
  • Biomatik
  • RayBiotech
  • R&D Systems
  • OriGene Technologies
  • Applied Biological Materials Inc. (abm)
  • Creative BioMart
  • Levprot Bioscience
  • Jubilant Biosys
  • Kinexus Bioinformatics
  • NorthX Biologics
  • Leinco Technologies
  • GenScript
  • KACTUS
  • G &P Biosciences
  • Boster Bio
  • Eurofins Discovery

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Recombinant Protein Production Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Recombinant Protein Production Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Recombinant Protein Production Service Market Dynamics
  1. 2.1 Custom Recombinant Protein Production Service Industry Trends
  2. 2.2 Custom Recombinant Protein Production Service Industry Drivers
  3. 2.3 Custom Recombinant Protein Production Service Industry Opportunities and Challenges
  4. 2.4 Custom Recombinant Protein Production Service Industry Restraints
3 Custom Recombinant Protein Production Service Market by Company
  1. 3.1 Global Custom Recombinant Protein Production Service Company Revenue Ranking in 2025
  2. 3.2 Global Custom Recombinant Protein Production Service Revenue by Company (2021-2026)
  3. 3.3 Global Custom Recombinant Protein Production Service Company Ranking (2024-2026)
  4. 3.4 Global Custom Recombinant Protein Production Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Recombinant Protein Production Service Company Product Type and Application
  6. 3.6 Global Custom Recombinant Protein Production Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Recombinant Protein Production Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Recombinant Protein Production Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Recombinant Protein Production Service Market by Type
  1. 4.1 Custom Recombinant Protein Production Service Type Introduction
  2. 4.1.1 Mammalian Cell Based
  3. 4.1.2 Bacteria Based
  4. 4.1.3 Insect Cell Based
  5. 4.1.4 Others
  6. 4.2 Global Custom Recombinant Protein Production Service Sales Value by Type
  7. 4.2.1 Global Custom Recombinant Protein Production Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Custom Recombinant Protein Production Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Custom Recombinant Protein Production Service Sales Value Share by Type (2021-2032)
5 Custom Recombinant Protein Production Service Market by Application
  1. 5.1 Custom Recombinant Protein Production Service Application Introduction
  2. 5.1.1 Basic Scientific Research
  3. 5.1.2 Monoclonal Antibody Drug Development
  4. 5.1.3 Therapeutic Protein Production
  5. 5.1.4 Mrna Vaccine Research
  6. 5.1.5 Others
  7. 5.2 Global Custom Recombinant Protein Production Service Sales Value by Application
  8. 5.2.1 Global Custom Recombinant Protein Production Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Custom Recombinant Protein Production Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Custom Recombinant Protein Production Service Sales Value Share by Application (2021-2032)
6 Custom Recombinant Protein Production Service Regional Value Analysis
  1. 6.1 Global Custom Recombinant Protein Production Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Recombinant Protein Production Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Recombinant Protein Production Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Recombinant Protein Production Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Recombinant Protein Production Service Sales Value (2021-2032)
  7. 6.3.2 North America Custom Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Recombinant Protein Production Service Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Recombinant Protein Production Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Recombinant Protein Production Service Sales Value (2021-2032)
  16. 6.6.2 South America Custom Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Recombinant Protein Production Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Recombinant Protein Production Service Sales Value Share by Country, 2025 VS 2032
7 Custom Recombinant Protein Production Service Country-level Value Analysis
  1. 7.1 Global Custom Recombinant Protein Production Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Recombinant Protein Production Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Recombinant Protein Production Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Recombinant Protein Production Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Recombinant Protein Production Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Recombinant Protein Production Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Recombinant Protein Production Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 VectorBuilder
  2. 8.1.1 VectorBuilder Company Information
  3. 8.1.2 VectorBuilder Business Overview
  4. 8.1.3 VectorBuilder Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 VectorBuilder Custom Recombinant Protein Production Service Product Portfolio
  6. 8.1.5 VectorBuilder Recent Developments
  7. 8.2 Proteos
  8. 8.2.1 Proteos Company Information
  9. 8.2.2 Proteos Business Overview
  10. 8.2.3 Proteos Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Proteos Custom Recombinant Protein Production Service Product Portfolio
  12. 8.2.5 Proteos Recent Developments
  13. 8.3 Creative Biolabs
  14. 8.3.1 Creative Biolabs Company Information
  15. 8.3.2 Creative Biolabs Business Overview
  16. 8.3.3 Creative Biolabs Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Creative Biolabs Custom Recombinant Protein Production Service Product Portfolio
  18. 8.3.5 Creative Biolabs Recent Developments
  19. 8.4 Charles River
  20. 8.4.1 Charles River Company Information
  21. 8.4.2 Charles River Business Overview
  22. 8.4.3 Charles River Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Custom Recombinant Protein Production Service Product Portfolio
  24. 8.4.5 Charles River Recent Developments
  25. 8.5 InVivo BioTech Services GmbH
  26. 8.5.1 InVivo BioTech Services GmbH Company Information
  27. 8.5.2 InVivo BioTech Services GmbH Business Overview
  28. 8.5.3 InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 InVivo BioTech Services GmbH Custom Recombinant Protein Production Service Product Portfolio
  30. 8.5.5 InVivo BioTech Services GmbH Recent Developments
  31. 8.6 eEnzyme
  32. 8.6.1 eEnzyme Company Information
  33. 8.6.2 eEnzyme Business Overview
  34. 8.6.3 eEnzyme Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 eEnzyme Custom Recombinant Protein Production Service Product Portfolio
  36. 8.6.5 eEnzyme Recent Developments
  37. 8.7 BiologicsCorp
  38. 8.7.1 BiologicsCorp Company Information
  39. 8.7.2 BiologicsCorp Business Overview
  40. 8.7.3 BiologicsCorp Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BiologicsCorp Custom Recombinant Protein Production Service Product Portfolio
  42. 8.7.5 BiologicsCorp Recent Developments
  43. 8.8 Biomatik
  44. 8.8.1 Biomatik Company Information
  45. 8.8.2 Biomatik Business Overview
  46. 8.8.3 Biomatik Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biomatik Custom Recombinant Protein Production Service Product Portfolio
  48. 8.8.5 Biomatik Recent Developments
  49. 8.9 RayBiotech
  50. 8.9.1 RayBiotech Company Information
  51. 8.9.2 RayBiotech Business Overview
  52. 8.9.3 RayBiotech Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RayBiotech Custom Recombinant Protein Production Service Product Portfolio
  54. 8.9.5 RayBiotech Recent Developments
  55. 8.10 R&D Systems
  56. 8.10.1 R&D Systems Company Information
  57. 8.10.2 R&D Systems Business Overview
  58. 8.10.3 R&D Systems Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 R&D Systems Custom Recombinant Protein Production Service Product Portfolio
  60. 8.10.5 R&D Systems Recent Developments
  61. 8.11 OriGene Technologies
  62. 8.11.1 OriGene Technologies Company Information
  63. 8.11.2 OriGene Technologies Business Overview
  64. 8.11.3 OriGene Technologies Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 OriGene Technologies Custom Recombinant Protein Production Service Product Portfolio
  66. 8.11.5 OriGene Technologies Recent Developments
  67. 8.12 Applied Biological Materials Inc. (abm)
  68. 8.12.1 Applied Biological Materials Inc. (abm) Company Information
  69. 8.12.2 Applied Biological Materials Inc. (abm) Business Overview
  70. 8.12.3 Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Applied Biological Materials Inc. (abm) Custom Recombinant Protein Production Service Product Portfolio
  72. 8.12.5 Applied Biological Materials Inc. (abm) Recent Developments
  73. 8.13 Creative BioMart
  74. 8.13.1 Creative BioMart Company Information
  75. 8.13.2 Creative BioMart Business Overview
  76. 8.13.3 Creative BioMart Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Creative BioMart Custom Recombinant Protein Production Service Product Portfolio
  78. 8.13.5 Creative BioMart Recent Developments
  79. 8.14 Levprot Bioscience
  80. 8.14.1 Levprot Bioscience Company Information
  81. 8.14.2 Levprot Bioscience Business Overview
  82. 8.14.3 Levprot Bioscience Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Levprot Bioscience Custom Recombinant Protein Production Service Product Portfolio
  84. 8.14.5 Levprot Bioscience Recent Developments
  85. 8.15 Jubilant Biosys
  86. 8.15.1 Jubilant Biosys Company Information
  87. 8.15.2 Jubilant Biosys Business Overview
  88. 8.15.3 Jubilant Biosys Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Jubilant Biosys Custom Recombinant Protein Production Service Product Portfolio
  90. 8.15.5 Jubilant Biosys Recent Developments
  91. 8.16 Kinexus Bioinformatics
  92. 8.16.1 Kinexus Bioinformatics Company Information
  93. 8.16.2 Kinexus Bioinformatics Business Overview
  94. 8.16.3 Kinexus Bioinformatics Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kinexus Bioinformatics Custom Recombinant Protein Production Service Product Portfolio
  96. 8.16.5 Kinexus Bioinformatics Recent Developments
  97. 8.17 NorthX Biologics
  98. 8.17.1 NorthX Biologics Company Information
  99. 8.17.2 NorthX Biologics Business Overview
  100. 8.17.3 NorthX Biologics Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 NorthX Biologics Custom Recombinant Protein Production Service Product Portfolio
  102. 8.17.5 NorthX Biologics Recent Developments
  103. 8.18 Leinco Technologies
  104. 8.18.1 Leinco Technologies Company Information
  105. 8.18.2 Leinco Technologies Business Overview
  106. 8.18.3 Leinco Technologies Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Leinco Technologies Custom Recombinant Protein Production Service Product Portfolio
  108. 8.18.5 Leinco Technologies Recent Developments
  109. 8.19 GenScript
  110. 8.19.1 GenScript Company Information
  111. 8.19.2 GenScript Business Overview
  112. 8.19.3 GenScript Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 GenScript Custom Recombinant Protein Production Service Product Portfolio
  114. 8.19.5 GenScript Recent Developments
  115. 8.20 KACTUS
  116. 8.20.1 KACTUS Company Information
  117. 8.20.2 KACTUS Business Overview
  118. 8.20.3 KACTUS Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 KACTUS Custom Recombinant Protein Production Service Product Portfolio
  120. 8.20.5 KACTUS Recent Developments
  121. 8.21 G &P Biosciences
  122. 8.21.1 G &P Biosciences Company Information
  123. 8.21.2 G &P Biosciences Business Overview
  124. 8.21.3 G &P Biosciences Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 G &P Biosciences Custom Recombinant Protein Production Service Product Portfolio
  126. 8.21.5 G &P Biosciences Recent Developments
  127. 8.22 Boster Bio
  128. 8.22.1 Boster Bio Company Information
  129. 8.22.2 Boster Bio Business Overview
  130. 8.22.3 Boster Bio Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Boster Bio Custom Recombinant Protein Production Service Product Portfolio
  132. 8.22.5 Boster Bio Recent Developments
  133. 8.23 Eurofins Discovery
  134. 8.23.1 Eurofins Discovery Company Information
  135. 8.23.2 Eurofins Discovery Business Overview
  136. 8.23.3 Eurofins Discovery Custom Recombinant Protein Production Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Eurofins Discovery Custom Recombinant Protein Production Service Product Portfolio
  138. 8.23.5 Eurofins Discovery Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst